Parkinson's disease: Mechanisms, translational models and management strategies

C Raza, R Anjum - Life sciences, 2019 - Elsevier
Parkinson's disease is a progressive neurodegenerative disorder. The classical motor
symptoms include resting tremors, bradykinesia, rigidity and postural instability and are …

Crosstalk between mammalian autophagy and the ubiquitin-proteasome system

NM Kocaturk, D Gozuacik - Frontiers in cell and developmental …, 2018 - frontiersin.org
Autophagy and the ubiquitin–proteasome system (UPS) are the two major intracellular
quality control and recycling mechanisms that are responsible for cellular homeostasis in …

A gene network regulating lysosomal biogenesis and function

M Sardiello, M Palmieri, A Di Ronza, DL Medina… - Science, 2009 - science.org
Lysosomes are organelles central to degradation and recycling processes in animal cells.
Whether lysosomal activity is coordinated to respond to cellular needs remains unclear. We …

Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies

A Ciechanover, YT Kwon - Experimental & molecular medicine, 2015 - nature.com
Mammalian cells remove misfolded proteins using various proteolytic systems, including the
ubiquitin (Ub)-proteasome system (UPS), chaperone mediated autophagy (CMA) and …

Chaperone-mediated autophagy: a unique way to enter the lysosome world

S Kaushik, AM Cuervo - Trends in cell biology, 2012 - cell.com
All cellular proteins undergo continuous synthesis and degradation. This permanent
renewal is necessary to maintain a functional proteome and to allow rapid changes in levels …

Ubiquitination and selective autophagy

S Shaid, CH Brandts, H Serve, I Dikic - Cell Death & Differentiation, 2013 - nature.com
Ubiquitination has long been recognised as a key determinator of protein fate by tagging
proteins for proteasomal degradation. Most recently, the ability of conjugated ubiquitin …

Alpha-synuclein aggregation pathway in Parkinson's disease: current status and novel therapeutic approaches

M Vidović, MG Rikalovic - Cells, 2022 - mdpi.com
Following Alzheimer's, Parkinson's disease (PD) is the second-most common
neurodegenerative disorder, sharing an unclear pathophysiology, a multifactorial profile …

The Lewy body in Parkinson's disease and related neurodegenerative disorders

K Wakabayashi, K Tanji, S Odagiri, Y Miki, F Mori… - Molecular …, 2013 - Springer
The histopathological hallmark of Parkinson's disease (PD) is the presence of fibrillar
aggregates referred to as Lewy bodies (LBs), in which α-synuclein is a major constituent …

Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties

C Garrido, M Brunet, C Didelot, Y Zermati, E Schmitt… - Cell cycle, 2006 - Taylor & Francis
Heat shock proteins (HSP) HSP27 and HSP70 are expressed in response to a wide variety
of physiological and environmental insults including anticancer chemotherapy, thus allowing …

The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of α‐synuclein aggregates

K Wakabayashi, K Tanji, F Mori, H Takahashi - Neuropathology, 2007 - Wiley Online Library
The histological hallmark of Parkinson's disease (PD) is the presence of fibrillar aggregates
called Lewy bodies (LBs). LB formation has been considered to be a marker for neuronal …